Pedram Keshavarz
Overview
Explore the profile of Pedram Keshavarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keshavarz P, Nezami N, Yazdanpanah F, Khojaste-Sarakhsi M, Mohammadigoldar Z, Azami M, et al.
Eur J Radiol
. 2025 Mar;
186:112031.
PMID: 40058175
No abstract available.
2.
Keshavarz P, Nezami N, Yazdanpanah F, Khojaste-Sarakhsi M, Mohammadigoldar Z, Azimi M, et al.
Eur J Radiol
. 2025 Feb;
184:111948.
PMID: 39892373
Purpose: To perform a systematic literature review of the efficacy of different AI models to predict HCC treatment response to transarterial chemoembolization (TACE), including overall survival (OS) and time to...
3.
Chiang J, Raman S, Ramakrishnan A, Keshavarz P, Sayre J, McWilliams J, et al.
J Vasc Interv Radiol
. 2024 Sep;
36(1):50-57.
PMID: 39322178
Purpose: To correlate preablation needle biopsy-acquired histopathologic grade of Liver Imaging Reporting and Data System (LI-RADS) 5 hepatocellular carcinoma (HCC) with postablation local tumor control rate, intrahepatic distant tumor progression-free...
4.
Keshavarz P, Bagherieh S, Nabipoorashrafi S, Chalian H, Rahsepar A, Kim G, et al.
Diagn Interv Imaging
. 2024 Apr;
105(7-8):251-265.
PMID: 38679540
Purpose: The purpose of this study was to systematically review the reported performances of ChatGPT, identify potential limitations, and explore future directions for its integration, optimization, and ethical considerations in...
5.
Mizandari M, Gotsiridze E, Keshavarz P, Nezami N, Azrumelashvili T, Nejati S, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610893
: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, with 10-40% of cases involving portal vein tumor thrombosis (PVTT), leading to poor outcomes and a short survival....
6.
Khalighfard S, Alizadeh A, Poorkhani A, Motahari M, Tahmasebifar A, Omranipour R, et al.
Eur J Pharmacol
. 2024 Mar;
969:176350.
PMID: 38458940
No abstract available.
7.
Habibzadeh A, Andishgar A, Kardeh S, Keshavarzian O, Taheri R, Tabrizi R, et al.
World Neurosurg
. 2023 Jul;
178:e371-e381.
PMID: 37482083
Objective: Accurate prediction of the morbidity and mortality outcomes of traumatic brain injury patients is still challenging. In the present study, we aimed to compare the predictive value of the...
8.
Rastegarian A, Bazrafshan A, Keshavarz P
Iran J Psychiatry
. 2023 Feb;
17(4):388-394.
PMID: 36817814
Happiness is an essential component in measuring quality of life. Today, rapid internet use proliferation has led to adverse effects on this behavior of individuals and family structures. The statistical...
9.
Farpour H, Ahmed F, Nasrollahi H, Nikbakht H, Dejman B, Keshavarz P, et al.
Pan Afr Med J
. 2023 Jan;
43:95.
PMID: 36660090
Introduction: little is known about social media (SM) use among breast cancer (BC) patients and their general health (GH). This study aimed to evaluate the impact of SM and sociodemographic...
10.
Khalighfard S, Khori V, Esmati E, Ahmadi F, Amiriani T, Poorkhani A, et al.
Med Oncol
. 2023 Jan;
40(2):74.
PMID: 36609711
Filgrastim, a recombinant type of granulocyte-colony stimulating factor (G-CSF), has a high potential to manage chemotherapy-induced leukopenia. It can increase stromal cell-derived factor 1 (SDF-1) which may stimulate C-X-C chemokine...